FDA Approved: VINORELBINE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for Vinorelbine submitted by Sagent Pharmaceuticals, making a generic version of the cancer drug available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Vinorelbine (Vinorelbine)

Snippet

SUPPL AP for VINORELBINE (VINORELBINE)